Co-Diagnostics Goodwill and Intangible Assets 2017-2023 | CODX
Co-Diagnostics goodwill and intangible assets from 2017 to 2023. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
| Co-Diagnostics Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023 | $26 |
| 2022 | $27 |
| 2021 | $42 |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| Co-Diagnostics Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $26 |
| 2023-09-30 | $26 |
| 2023-06-30 | $27 |
| 2023-03-31 | $27 |
| 2022-12-31 | $27 |
| 2022-09-30 | $42 |
| 2022-06-30 | $42 |
| 2022-03-31 | $42 |
| 2021-12-31 | $42 |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | $0 |
| 2016-12-31 | |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.039B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.165B | 15.45 |
| Cencora (COR) | United States | $44.692B | 17.42 |
| ICON (ICLR) | Ireland | $25.998B | 24.54 |
| DiDi Global (DIDIY) | China | $24.302B | 0.00 |
| Avantor (AVTR) | United States | $16.893B | 24.87 |
| CochLear (CHEOY) | Australia | $14.118B | 0.00 |
| Viatris (VTRS) | United States | $14.074B | 4.05 |
| Revvity (RVTY) | United States | $12.701B | 22.25 |
| Medpace Holdings (MEDP) | United States | $12.416B | 40.85 |
| Charles River Laboratories (CRL) | United States | $12.119B | 22.09 |
| Natera (NTRA) | United States | $11.739B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.436B | 0.00 |
| Solventum (SOLV) | United States | $11.160B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.373B | 0.00 |
| HealthEquity (HQY) | United States | $6.801B | 50.81 |
| Organon (OGN) | United States | $5.318B | 5.04 |
| Bausch + Lomb (BLCO) | Canada | $5.074B | 20.34 |
| Doximity (DOCS) | United States | $4.589B | 34.17 |
| PACS (PACS) | United States | $3.743B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.254B | 30.12 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| GoodRx Holdings (GDRX) | United States | $2.951B | 149.40 |
| Life Times (LTH) | United States | $2.907B | 30.79 |
| Premier (PINC) | United States | $2.483B | 9.09 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.169B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.955B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.673B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.493B | 0.00 | |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.780B | 8.07 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.598B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.533B | 0.00 |
| CareDx (CDNA) | United States | $0.527B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.509B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.82 |
| Sonida Senior Living (SNDA) | United States | $0.449B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| DocGo (DCGO) | United States | $0.385B | 61.67 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sera Prognostics (SERA) | United States | $0.322B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.070B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |